MicuRx Pharmaceuticals
Latest round
- Series E
Last raised
- Dec 2020
Total raised
- $255M
Investors
- 17
About MicuRx Pharmaceuticals
Founded in 2012 and based in Shanghai, China, MicuRx Pharmaceuticals, Inc. is a pharmaceutical company that focuses on the R&D and commercialization of new drugs for infectious diseases. The company was established by Dr. Zhengyu Yuan and Dr. Mikhail F. Gordeev. In August 2022, the company was listed on Shanghai Stock Exchange under the number 688373. The company provides new drugs for infections caused by multidrug-resistant bacteria. The company's first commercialization application drug, contezolid, was treated for drug-resistant Gram-postive bacteria caused by skin and soft tissue infection. And contezolid was approved new drug application by China National Medical Products Administration (NMPA) in June 2021. The company generates revenue by researching and developing antibacterial drugs and other related products.
Who invested in MicuRx Pharmaceuticals
17 investors across 6 rounds
See all investors in MicuRx Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about MicuRx Pharmaceuticals
Who invested in MicuRx Pharmaceuticals?
MicuRx Pharmaceuticals has 17 investors on record across 6 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has MicuRx Pharmaceuticals raised?
MicuRx Pharmaceuticals has raised 6 venture rounds. Sign up free to see how much each round raised and the total.
When did MicuRx Pharmaceuticals last raise money?
MicuRx Pharmaceuticals's most recent round on record is a Series E, in Dec 2020.
What does MicuRx Pharmaceuticals do?
Founded in 2012 and based in Shanghai, China, MicuRx Pharmaceuticals, Inc.
Where is MicuRx Pharmaceuticals headquartered?
MicuRx Pharmaceuticals is headquartered in Shanghai, China.
Which VCs invest in companies like MicuRx Pharmaceuticals?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at MicuRx Pharmaceuticals's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series E
Raising like MicuRx Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.